CDK4 and neoplasm: In addition, CDK4/6 inhibitors suppress the proliferation of Tregs and promote cytotoxic T cell- mediated clearance of tumor cells.134 In vitro and in vivo studies revealed that CDK4/6 inhibition resulted in increased anti-tumor activity and sensitivity to the PD-1 blockade.135